[HTML][HTML] Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirrò, C Romano, MS Pennisi… - Molecular cancer, 2018 - Springer
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia.
M Massimino, S Stella, E Tirrò, C Romano… - Molecular …, 2018 - search.ebscohost.com
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
[HTML][HTML] Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirrò, C Romano… - Molecular …, 2018 - ncbi.nlm.nih.gov
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
[HTML][HTML] Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirrò… - Molecular …, 2018 - molecular-cancer.biomedcentral …
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia.
M Massimino, S Stella, E Tirrò, C Romano… - Molecular …, 2018 - europepmc.org
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
[引用][C] Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirrò, C Romano… - Molecular …, 2018 - cir.nii.ac.jp
[PDF][PDF] Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirrò, C Romano, MS Pennisi… - drugs, 2018 - iris.unict.it
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
[引用][C] Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirro, C Romano… - Molecular Cancer …, 2018 - jglobal.jst.go.jp
Carcinogenesis; IRF5 is a target of BCR-ABL kinase activity and reduces CML cell
proliferation; M Massimino, ML Consoli, M Mesuraca, F Stagno, E Tirro, S Stella, MS Pennisi …
proliferation; M Massimino, ML Consoli, M Mesuraca, F Stagno, E Tirro, S Stella, MS Pennisi …
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E TirrA, C Romano… - Molecular …, 2018 - go.gale.com
Background Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder characterized
by neoplastic transformation of the Hematopoietic Stem Cell (HSC) which displays a …
by neoplastic transformation of the Hematopoietic Stem Cell (HSC) which displays a …
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirrò, C Romano… - Molecular …, 2018 - pubmed.ncbi.nlm.nih.gov
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …